Zobrazeno 1 - 10
of 352
pro vyhledávání: '"HP Kiem"'
Publikováno v:
Blood. 86:3265-3267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1b7a793b61c839a5d898e86c8b8f79e
https://doi.org/10.1182/blood.v86.8.3265.bloodjournal8683265
https://doi.org/10.1182/blood.v86.8.3265.bloodjournal8683265
Autor:
Hp, Kiem, Gb, Mcdonald, David Myerson, Cl, Spurgeon, Hj, Deeg, Je, Sanders, Doney K, Fr, Appelbaum, Km, Sullivan, Rp, Witherspoon, Storb R
Publikováno v:
Europe PubMed Central
Between 1971 and 1989 we have treated 19 patients with hepatitis-associated aplastic anemia by marrow transplantation from their HLA-identical siblings following conditioning with 200 mg/kg cyclophosphamide (Cy) administered over a period of 4 days.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::097d2eec0c93976cea72f7cf51432140
https://pubmed.ncbi.nlm.nih.gov/9118304
https://pubmed.ncbi.nlm.nih.gov/9118304
Autor:
Jordi Barquinero, Darovsky B, Goehle S, Graham T, Hp, Kiem, Fg, Schuening, Seidel K, Storb R, von Kalle C
Publikováno v:
Europe PubMed Central
We have studied the role of different conditioning regimens for engraftment of genetically marked hematopoietic repopulating cells in dogs. Peripheral blood (PB) and/or marrow cells collected after treatment with recombinant canine stem cell factor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c1d3d8e017789247bb5e783096ddcc30
https://pubmed.ncbi.nlm.nih.gov/7532034
https://pubmed.ncbi.nlm.nih.gov/7532034
Autor:
Hp, Kiem, Darovsky B, von Kalle C, Goehle S, Stewart D, Graham T, Hackman R, Fr, Appelbaum, Hj, Deeg, Dusty Miller
Publikováno v:
Europe PubMed Central
Genetically marked peripheral blood progenitor cells were used to investigate their contribution to long-term hematopoietic reconstitution after autologous marrow and peripheral blood cell transplantation. After autologous marrow harvest and cryopres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5aa8a1742fa39488da8e7ec5e189067
https://pubmed.ncbi.nlm.nih.gov/8123838
https://pubmed.ncbi.nlm.nih.gov/8123838
Autor:
Li C; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA. Electronic address: cli1239@uw.edu., Georgakopoulou A; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA., Paschoudi K; Gene and Cell Therapy Center, Hematology Department, George Papanicolaou Hospital, Thessaloniki, Greece., Anderson AK; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA., Huang L; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA., Gil S; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA., Giannaki M; Second Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Vlachaki E; Second Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Newby GA; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA; Johns Hopkins University, Department of Genetic Medicine, Baltimore, MD, USA., Liu DR; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA., Yannaki E; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA; Gene and Cell Therapy Center, Hematology Department, George Papanicolaou Hospital, Thessaloniki, Greece., Kiem HP; Stem and Gene Therapy Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Lieber A; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA 98195, USA.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Dec 04; Vol. 32 (12), pp. 4353-4371. Date of Electronic Publication: 2024 Oct 28.
Autor:
Georgakopoulou A; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA., Li C; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA., Kiem HP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Lieber A; University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Sep 21; Vol. 32 (4), pp. 101343. Date of Electronic Publication: 2024 Sep 21 (Print Publication: 2024).
Autor:
Nicolai CJ; Umoja Biopharma, Seattle, WA., Parker MH; Umoja Biopharma, Seattle, WA., Qin J; Umoja Biopharma, Seattle, WA., Tang W; Umoja Biopharma, Seattle, WA., Ulrich-Lewis JT; Umoja Biopharma, Seattle, WA., Gottschalk RJ; Umoja Biopharma, Seattle, WA., Cooper SE; Umoja Biopharma, Seattle, WA., Hernandez Lopez SA; Umoja Biopharma, Seattle, WA., Parrilla D; Umoja Biopharma, Seattle, WA., Mangio RS; Umoja Biopharma, Seattle, WA., Ericson NG; Umoja Biopharma, Seattle, WA., Brandes AH; Umoja Biopharma, Seattle, WA., Umuhoza S; Umoja Biopharma, Seattle, WA., Michels KR; Umoja Biopharma, Seattle, WA., McDonnell MM; Umoja Biopharma, Seattle, WA., Park LY; Umoja Biopharma, Seattle, WA., Shin S; Umoja Biopharma, Seattle, WA., Leung WH; Umoja Biopharma, Seattle, WA., Scharenberg AM; Umoja Biopharma, Seattle, WA., Kiem HP; Fred Hutchinson Cancer Center, Seattle, WA., Larson RP; Umoja Biopharma, Seattle, WA., Beitz LO; Umoja Biopharma, Seattle, WA., Ryu BY; Umoja Biopharma, Seattle, WA.
Publikováno v:
Blood [Blood] 2024 Aug 29; Vol. 144 (9), pp. 977-987.
Autor:
Li C; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA., Anderson AK; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA., Ruminski P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Rettig M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Karpova D; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Kiem HP; Stem and Gene Therapy Program, Fred Hutchinson Cancer Research Center, Seattle, WA., DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Lieber A; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 4089-4101.
Autor:
Fiorenza S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia., Lim SYT; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Laszlo GS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kimble EL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA 98195, USA., Phi TD; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Lunn-Halbert MC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kirchmeier DR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Huo J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kiem HP; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Turtle CJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia., Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
Publikováno v:
Molecular therapy. Oncology [Mol Ther Oncol] 2024 Jul 31; Vol. 32 (3), pp. 200854. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024).
Autor:
Saha A; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Palchaudhuri R; Magenta Therapeutics, Cambridge, MA., Lanieri L; Magenta Therapeutics, Cambridge, MA., Hyzy S; Magenta Therapeutics, Cambridge, MA., Riddle MJ; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Panthera J; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Eide CR; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Tolar J; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Panoskaltsis-Mortari A; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Gorfinkel L; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Tkachev V; Massachusetts General Hospital Center for Transplantation Sciences, Mass General Brigham and Massachusetts General Hospital, Boston, MA., Gerdemann U; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Alvarez-Calderon F; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Palato ER; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., MacMillan ML; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Wagner JE; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Kean LS; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA., Osborn MJ; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Kiem HP; Department of Medicine, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA., Scadden DT; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Stem Cell Institute, Cambridge, MA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA., Olson LM; Magenta Therapeutics, Cambridge, MA., Blazar BR; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
Publikováno v:
Blood [Blood] 2024 May 23; Vol. 143 (21), pp. 2201-2216.